Prognostic significance of a reduced glomerular filtration rate and interaction with microalbuminuria in resistant hypertension: A cohort study

Journal of Hypertension

Volumn 29, Issue 10, 2011, Pages 2014-2023

  Salles, Gil F ^a   Cardoso, Claudia R L ^a   Pereira, Vinicius S ^a   Fiszman, Roberto ^a   Muxfeldt, Elizabeth S ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cardiovascular risk; Chronic kidney disease; Glomerular filtration rate; Microalbuminuria; Mortality; Resistant hypertension

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORBIDITY; MORTALITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RESISTANT HYPERTENSION; ALBUMINURIA; COHORT ANALYSIS; DISEASE FREE SURVIVAL; DRUG RESISTANCE; HYPERTENSION; MIDDLE AGED; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL;

ANTIHYPERTENSIVE AGENT;

AGED; ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; COHORT STUDIES; DISEASE-FREE SURVIVAL; DRUG RESISTANCE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 84856017910     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834adb09     Document Type: Article

References (37)

1. Brosius FC, Hostetter TH, Kelepouris E, Mitsnefes MM, Moe SM, Moore MA, et al. Detection of chronic kidney disease in patients with or at increasedrisk of cardiovascular disease. A science advisory from the American Heart Association Kidneyand Cardiovascular Disease Council; the Councilson High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2006;114:1083-1087. (Pubitemid 44358886)
2. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-S266.
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-1305.
4. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, et al. Chronic kidney disease as a risk factor for cardiovascular disease and allcause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004;15:1307-1315. (Pubitemid 38526012)
5. Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT Jr, Whelton PK, et al., for the ALLHAT Collaborative Research Group. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med 2006;144:172-180. (Pubitemid 46780689)
6. Ruilope LM, Zanchetti A, Julius S, McInnes GT, Segura J, Stolt P, et al., for the VALUE investigators. Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial. J Hypertens 2007;25:1473-1479. (Pubitemid 46918836)
7. Ford I, Bezlyak V, Stott DJ, Sattar N, Packard CJ, Perry I, et al. Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis. PLoS Med 2009;6:e16.
8. Kurth T, de Jong PE, Cook NR, Buring JE, Ridker PM. Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study. BMJ 2009;338:b2392.
9. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154-2169. (Pubitemid 37337595)
10. Gansevoort RT, de Jong PE. The case for using albuminuria in staging chronic kidney disease. J Am Soc Nephrol 2009;20:465-468.
11. Tonelli M, Muntner P, Lloyd A, Manns BJ, James MT, Klarenbach S, et al., for the Alberta Kidney Disease Network. Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease. A cohort study. Ann Intern Med 2011;154:12-21.
12. Hallan S, Astor B, Romundstad S, Aasarod K, Kvenild K, Coresh J. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals. Arch Intern Med 2007;167:2490-2496. (Pubitemid 350254909)
13. Foster MC, Hwang S-J, Larson MG, Parikh NI, Meigs JB, Vasan RS, et al. Cross-classification of microalbuminuria and reduced glomerular filtration rate. Associations between cardiovascular disease risk factors and clinical outcomes. Arch Intern Med 2007;167:1386-1392. (Pubitemid 47052437)
14. Färbom P, Wahlstrand B, Almgren P, Skrtic S, Lanke J, Weiss L, et al. Interaction between renal function and microalbuminuria for cardiovascular risk in hypertension. The Nordic Diltiazem study. Hypertension 2008;52:115-122.
15. Di Angelantonio E, Chowdhury R, Sarwar N, Aspelund T, Danesh J, Gudnason V. Chronic kidney disease and risk of major cardiovascular disease and nonvascular mortality: prospective population based cohort study. BMJ 2010;341:c4986.
16. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, et al., for the Alberta Kidney Disease Network. Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010;303:423-429.
17. Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375:2073-2081.
18. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008;51:1403-1419.
19. Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension 1998;31:712-718.
20. Salles G, Cardoso C, Muxfeldt E. Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med 2008;168:2340-2346.
21. Muxfeldt ES, Cardoso C R L, Salles G. Prognostic value of the nocturnal blood pressure reduction in resistant hypertension. Arch Intern Med 2009;169:874-880.
22. Salles G, Cardoso C, Fiszman R, Muxfeldt E. Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension. Atherosclerosis 2011;216:199-204.
23. Muxfeldt ES, Bloch KV, Nogueira AR, Salles GF. Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension. Blood Press Monit 2003;8:181-185. (Pubitemid 41623175)
24. Muxfeldt ES, Bloch KV, Nogueira Ada R, Salles GF. True resistant hypertension: is it possible to be recognized in the office? Am J Hypertens 2005;18:1534-1540. (Pubitemid 41814672)
25. Bloch KV, Melo AN, Nogueira AR. Prevalence of antihypertensive treatment adherence in patients with resistant hypertension and validation of three indirect methods for assessing treatment adherence. Cad Saude Publica 2008;24:2979-2984.
26. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
27. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470. (Pubitemid 29135798)
28. Murthy K, Stevens LA, Stark PC, Levey AS. Variation in the serum creatinine assay calibration: a practical application to glomerular filtration rate estimation. Kidney Int 2005;68:1884-1887. (Pubitemid 43169935)
29. Jones CR, Taylor K, Chowienczyk P, Poston L, Shennan AH. A validation of the Mobil O Graph (version 12) ambulatory blood pressure monitor. Blood Press Monit 2000;5:233-238.
30. Astor BC, Hallan SI, Miller ER, Yeung E, Coresh J. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol 2008;167:1226-1234. (Pubitemid 351670638)
31. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001;134:629-636. (Pubitemid 32322240)
32. Garg AX, Clark WF, Haynes RB, House AA. Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int 2002;61:1486-1494. (Pubitemid 34304510)
33. Go SA, Lo JC. Epidemiology of nondialysis-requiring chronic kidney disease and cardiovascular disease. Curr Opin Nephrol Hypertens 2006;15:296-302.
34. Hallan S, Asberg A, Lindberg M, Johnsen H. Validation of the Modification of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis 2004;44:84-93. (Pubitemid 38880931)
35. Coresh J, Stevens LA. Kidney function estimating equations: where do we stand? Curr Opin Nephrol Hypertens 2006;15:276-284.
36. Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002;39:920-929. (Pubitemid 34454210)
37. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005;352:2049-2060. (Pubitemid 40664306)